Absolutely, and I think most people here realize that 2.95 billion shares at a price of 0.005 comes out to a market cap of $14.75 million, which is (really) what is undervalued here. Some stocks trade on rumor and can hit near their potential market cap before news is released, but BMSN seems to only respond to news; no doubt due to the touch-and-go nature of drug trials and approvals. Once we see these confirmatory releases, the market cap could be (should be!) well within the hundreds of millions (i.e., share price in the nickels to dimes). So far most signs are pointing to YES based on some the DD that's come through recently.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.